- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
USPSTF Stands by 2-Year Mammography Decision
Women with an average risk of breast cancer should have screening mammography every 2 years during ages 50 to 74, according to updated recommendations from the United States Preventive Services Task Force.
Women with an average risk of breast cancer should have screening mammography every 2 years during ages 50 to 74, according to updated recommendations from the United States Preventive Services Task Force (USPSTF).
After reviewing available data, the panel concluded that women, ages 60 to 69, derive the greatest benefit from screening mammography in terms of preventing breast cancer death.
Selected women 40 to 49 might reduce their risk of dying of breast cancer with regular mammographic screening, but the benefit is much smaller as compared with older women and leads to too many false-positive tests and unnecessary breast biopsies, the USPSTF concluded in a draft document posted on the task force website. The posting begins a 30-day public comment period.
With the release of the draft, the USPSTF stands by most of its previous recommendation, published in 2009.
Read more at Medpage Today: http://bit.ly/1QeJCFO
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
